OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Vertex Pharmaceuticals/  US92532F1003  /

IEX
2024-11-12  9:59:58 PM Chg. -11.82 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
489.96USD -2.36% 45,452
Turnover: 22.55 mill.		 -Bid Size: - -Ask Size: - 126.19 bill.USD - 34.88

Assets

 2011
US GAAP
in mill. USD		 2012
US GAAP
in mill. USD		 2013
US GAAP
in mill. USD		 2014
US GAAP
in mill. USD		 2015
US GAAP
in mill. USD
Property and Equipment
  133.2000   433.6000   696.9000   715.8120   697.7150
Intangible Assets
  663.5000   663.5000   0.0000   29   284.3400
Long-Term Investments
  34.1000   31.9000   .1000   -   -
Fixed Assets
  -   -   -   788.1680   1,091.7220
Inventories
  112.4000   30.5000   14.1000   30.8480   57.2070
Accounts Receivable
  183.1000   143.3000   85.5000   75.9640   177.6390
Cash and Cash Equivalents
  475.3000   489.4000   569.3000   625.2590   714.7680
Current Assets
  1,331.2000   1,589.6000   1,588.6000   1,546.5110   1,407.1530
Total Assets
  2,204.3000   2,759.3000   2,319   2,334.6790   2,498.8750

 

Liabilities

 2011
US GAAP
in mill. USD		 2012
US GAAP
in mill. USD		 2013
US GAAP
in mill. USD		 2014
US GAAP
in mill. USD		 2015
US GAAP
in mill. USD
Accounts Payable
  74.6000   101.3000   49.3000   71.1940   74.9420
Long-term debt
  -   -   -   792.9350   739.3970
Liabilities to Banks
  0.0000   0.0000   0.0000   280.6000   224
Provisions
  255.8000   281.1000   -   -   110.4000
Liabilities
  1,275.8000   1,563.4000   962.6000   1,238.4960   1,405.2470
Share Capital
  -   -   -   2.3850   2.4270
Total Equity
  928.5000   1,195.9000   1,356.4000   1,096.1830   1,093.6280
Minority Interests
  141.6000   196.7000   0.0000   21.1770   153.6610
Total liabilities equity
  2,204.3000   2,759.3000   2,319   2,334.6790   2,498.8750

 

Income Statement

 2011
US GAAP
in mill. USD		 2012
US GAAP
in mill. USD		 2013
US GAAP
in mill. USD		 2014
US GAAP
in mill. USD		 2015
US GAAP
in mill. USD
Revenues
  1,410.6000   1,527   1,212   580.4150   1,032.3360
Depreciation (total)
  -   -   -   63.2570   62.3430
Operating Result
  113.8000   2.3000   -903.4000   -692.4120   -466.8790
Interest Income
  -36.6000   -14.8000   -22.7000   72.8630   84.2060
Income Before Taxes
  60.4000   -12.4000   -976.1000   -734.8750   -557.8000
Income Taxes
  19.3000   38.8000   -288.6000   6.9580   30.3810
Minority Interests Profit
  -11.6000   -55.9000   242.5000   4.1900   31.8470
Net Income
  29.6000   -107   -445   -738.5550   -556.3340

 

Per Share

 2011
US GAAP
in USD		 2012
US GAAP
in USD		 2013
US GAAP
in USD		 2014
US GAAP
in USD		 2015
US GAAP
in USD
Earnings per Share
  0.1400   -0.5000   -1.9800   -3.1400   -2.3100
Dividend per Share
  0.0000   0.0000   0.0000   -   -

 

Cash Flow

 2011
US GAAP
in mill. USD		 2012
US GAAP
in mill. USD		 2013
US GAAP
in mill. USD		 2014
US GAAP
in mill. USD		 2015
US GAAP
in mill. USD
Cash Flow from Operating Activities
  143.7000   267.8000   -51.6000   -513.1990   -365.4320
Cash Flow from Investing Activities
  212.4000   -425.8000   -54.1000   73.9590   268.8560
Cash Flow from Financing
  -124.2000   172.2000   180.9000   497.3760   188.9190
Decrease / Increase in Cash
  232.1000   14.1000   79.9000   55.9600   89.5090
Employees
  2,000   2,200   1,800   1,830   1,950